Join the Chronic Spasticity group to help and get support from people like you.
Chronic Spasticity News (Page 2)
Relaxing Immersive Virtual Reality Interventions Acceptable, Feasible
TUESDAY, Oct. 17, 2023 – Relaxing immersive virtual reality (VR) interventions are acceptable and feasible and can offer benefits to patients with cancer, according to a review published online Oct....
Sociodemographic Factors Before MS Diagnosis Tied to Disease Severity
FRIDAY, Sept. 29, 2023 – Education, income, and marital status prior to multiple sclerosis (MS) onset are associated with future symptom and disability severity, according to a study published...
aHSCT Beneficial for Most Patients With Relapsing-Remitting MS
TUESDAY, Sept. 26, 2023 – Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most...
FDA Approves Expanded Botox (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License...
FDA Approves Movement Disorder Drug from CNS Therapeutics: Gablofen (Baclofen Injection) for the Treatment of Severe Spasticity
ST. PAUL, Minn.--(BUSINESS WIRE)--Nov 23, 2010 - Today, CNS Therapeutics announced the FDA approval of Gablofen (baclofen injection) for use in the management of severe spasticity, giving healthcare...
Botox (onabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults
IRVINE, Calif.--(BUSINESS WIRE)--Mar 10, 2010 - Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of...